Catalyst Wire Dossier Catalyst Wire Dossier

Topiramate OROS Controlled-Release

topiramate · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topiramate OROS Controlled-Release, covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin [Phase 2]

See pricing